Brief Report
No access
Published Online: 7 October 2013

Characterizing Episodic Breathlessness in Patients with Advanced Disease

Publication: Journal of Palliative Medicine
Volume 16, Issue Number 10

Abstract

Background: Episodic breathlessness is a common and distressing symptom in advanced cancer and nonmalignant diseases but there is a lack of evidence on the characteristics of the symptom.
Objective: The aim of this study was to determine the duration, severity, frequency and timing of breathlessness episodes in patients with advanced diseases.
Methods: Explorative analysis of pooled cross-sectional data on episodic breathlessness collected in personal interviews with patients suffering from chronic obstructive pulmonary disease, lung cancer, chronic heart failure, or motor neuron disease. Interviews were conducted as part of two studies in the UK and in Germany that included the same questions on duration, frequency, timing, and peak severity of breathlessness episodes. Severity was measured on the modified Borg scale (0–10).
Results: One hundred and twenty-nine patients, 61% male, mean age of 67 years (SD 9.8), were included. The episodes described were mainly short (75%≤10 min), severe (mean 6.5 (SD 2.4), and occurred mostly daily. Frequency of episodes triggered by exertion could hardly be determined as these varied depending on patients' activity.
Conclusion: Our study reveals clinically important information on the characteristics of episodic breathlessness in patients with advanced diseases. Findings have implications for the treatment of episodic breathlessness since most short-acting drugs in use have a longer onset of action compared to the duration of episodes. We need to determine patient-relevant therapeutic targets for future evaluation of adequate pharmacological and nonpharmacological management options that are urgently warranted.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Parshall MBSchwartzstein RMAdams LBanzett RBManning HLBourbeau JCalverley PMGift AGHarver ALareau SCMahler DAMeek PMO'Donnell DE. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Thoracic SocietyAm J Respir Crit Care Med2012185435-452. 1. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, Mahler DA, Meek PM, O'Donnell DE. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Thoracic Society. Am J Respir Crit Care Med 2012;185:435–452.
2.
Booth SSilvester STodd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and caregiversPalliat Support Care20031337-344. 2. Booth S, Silvester S, Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and caregivers. Palliat Support Care 2003;1:337–344.
3.
Solano JPGomes BHigginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal diseaseJ Pain Symptom Manage20063158-69. 3. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006;31:58–69.
4.
Tripodoro VADe Vito EL. Management of dyspnea in advanced motor neuron diseasesCurr Opin Support Palliat Care20082173-179. 4. Tripodoro VA, De Vito EL. Management of dyspnea in advanced motor neuron diseases. Curr Opin Support Palliat Care 2008;2:173–179.
5.
Reddy SKParsons HAElsayem APalmer JLBruera E. Characteristics and correlates of dyspnea in patients with advanced cancerJ Palliat Med20091229-36. 5. Reddy SK, Parsons HA, Elsayem A, Palmer JL, Bruera E. Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med 2009;12:29–36.
6.
Johnson MJAbernethy APCurrow DC. Gaps in the evidence base of opioids for refractory breathlessness. A future work plan?J Pain Symptom Manage201243614-624. 6. Johnson MJ, Abernethy AP, Currow DC. Gaps in the evidence base of opioids for refractory breathlessness. A future work plan? J Pain Symptom Manage 2012;43:614–624.
7.
Simon STHigginson IJBenalia HGysels MMurtagh FESpicer JBausewein C. Episodic and Continuous Breathlessness: A New Categorization of BreathlessnessJ Pain Symptom Manage2012. 7. Simon ST, Higginson IJ, Benalia H, Gysels M, Murtagh FE, Spicer J, Bausewein C. Episodic and Continuous Breathlessness: A New Categorization of Breathlessness. J Pain Symptom Manage 2012; DOI 10.1016/j.jpainsymman.2012.06.008.
8.
Simon STBausewein CSchildmann EHigginson IJMagnussen HScheve CRamsenthaler C. Episodic breathlessness in patients with advanced disease: a systematic reviewJ Pain Symptom Manage2012. 8. Simon ST, Bausewein C, Schildmann E, Higginson IJ, Magnussen H, Scheve C, Ramsenthaler C. Episodic breathlessness in patients with advanced disease: a systematic review. J Pain Symptom Manage 2012; DOI 10.1016/j.jpainsymman.2012.02.022.
9.
Simon STHigginson IJBenalia HGysels MMurtagh FEMSpicer JBausewein C. Episodic breathlessness: types and patternsPalliative Medicine2013in progress. 9. Simon ST, Higginson IJ, Benalia H, Gysels M, Murtagh FEM, Spicer J, Bausewein C. Episodic breathlessness: types and patterns. Palliative Medicine 2013 in progress.
10.
Burdon JJuniper EKillian KHargreave FECampbell EJ. The perception of breathlessness in asthmaAm Rev Respir Disease1982126825-828. 10. Burdon J, Juniper E, Killian K, Hargreave FE, Campbell EJ. The perception of breathlessness in asthma. Am Rev Respir Disease 1982;126:825–828.
11.
Davies AZeppetella GAndersen SDamkier AVejlgaard TNauck FRadbruch LSjolund KFStenberg MBuchanan A. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategiesEur J Pain201115756-763. 11. Davies A, Zeppetella G, Andersen S, Damkier A, Vejlgaard T, Nauck F, Radbruch L, Sjolund KF, Stenberg M, Buchanan A. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain 2011;15:756–763.
12.
Maddocks MTaylor VKlezlova REngland RManderson CWilcock A. When will I get my breath back? Recovery time of exercise-induced breathlessness in patients with thoracic cancerLung Cancer201276128-129. 12. Maddocks M, Taylor V, Klezlova R, England R, Manderson C, Wilcock A. When will I get my breath back? Recovery time of exercise-induced breathlessness in patients with thoracic cancer. Lung Cancer 2012;76:128–129.
13.
Jennings ALDavies ANHiggins JPBroadley K. Opioids for the palliation of breathlessness in terminal illness [Review]Cochrane Database Syst Rev20014CD002066. 13. Jennings AL, Davies AN, Higgins JP, Broadley K. Opioids for the palliation of breathlessness in terminal illness [Review]. Cochrane Database Syst Rev 2001(4):CD002066.
14.
Freye ELevy JVBraun D. Effervescent morphine results in faster relief of breakthrough pain in patients compared to immediate release morphine sulfate tabletPain Pract20077324-331. 14. Freye E, Levy JV, Braun D. Effervescent morphine results in faster relief of breakthrough pain in patients compared to immediate release morphine sulfate tablet. Pain Pract 2007;7:324–331.
15.
Jensen DAlsuhail AViola RDudgeon DJWebb KAO'Donnell DE. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary diseaseJ Pain Symptom Manage201243706-719. 15. Jensen D, Alsuhail A, Viola R, Dudgeon DJ, Webb KA, O'Donnell DE. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease. J Pain Symptom Manage 2012;43:706–719.
16.
Simon STWeingärtner VHigginson IJVoltz RBausewein C. Definition, categorization, and terminology of episodic breathlessness: consensus by an international Delphi SurveyJ Pain Symptom Manage2013(in press). 16. Simon ST, Weingärtner V, Higginson IJ, Voltz R, Bausewein C. Definition, categorization, and terminology of episodic breathlessness: consensus by an international Delphi Survey. J Pain Symptom Manage 2013 (in press).

Information & Authors

Information

Published In

cover image Journal of Palliative Medicine
Journal of Palliative Medicine
Volume 16Issue Number 10October 2013
Pages: 1275 - 1279
PubMed: 24053592

History

Published online: 7 October 2013
Published in print: October 2013
Published ahead of print: 20 September 2013
Accepted: 20 May 2012

Permissions

Request permissions for this article.

Authors

Affiliations

Vera Weingärtner
Department of Palliative Medicine, Center of Integrated Oncology (BMBF O1KN1106), Cologne/Bonn and Clinical Trials Unit, University Hospital of Cologne, Cologne, Germany.
Claudia Bausewein
Interdisciplinary Centre for Palliative Medicine, University Hospital, Munich, Germany.
Department of Palliative Care, Policy and Rehabilitation—WHO Collaborating Centre for Palliative Care and Older People, Cicely Saunders Institute, King's College London, London, United Kingdom.
Irene J. Higginson
Department of Palliative Care, Policy and Rehabilitation—WHO Collaborating Centre for Palliative Care and Older People, Cicely Saunders Institute, King's College London, London, United Kingdom.
Christine Scheve
Institute of Palliative Care, Oldenburg, Germany.
Fliss E.M. Murtagh
Department of Palliative Care, Policy and Rehabilitation—WHO Collaborating Centre for Palliative Care and Older People, Cicely Saunders Institute, King's College London, London, United Kingdom.
Raymond Voltz
Department of Palliative Medicine, Center of Integrated Oncology (BMBF O1KN1106), Cologne/Bonn and Clinical Trials Unit, University Hospital of Cologne, Cologne, Germany.
Steffen T. Simon
Department of Palliative Medicine, Center of Integrated Oncology (BMBF O1KN1106), Cologne/Bonn and Clinical Trials Unit, University Hospital of Cologne, Cologne, Germany.
Institute of Palliative Care, Oldenburg, Germany.

Notes

Address correspondence to:Steffen T. Simon, MD, MScDepartment of Palliative MedicineUniversity Hospital of CologneKerpener Strasse 62, 50924 Cologne,Germany
E-mail: [email protected]

Author Disclosure Statement

This study was presented as a poster presentation in 2012 at the 9th Congress of the German Association for Palliative Medicine, Berlin, Germany.
Steffen Simon and Rau Voltz received research funding for a clinical trial from TEVA Ltd., after this study was conducted. All of the other authors declare that no conflicting financial interests exist.

Funding

This study was supported by a research grant from the Dr. Werner Jackstädt Foundation, Wuppertal, Germany, the Cicely Saunders Institute, King's College London, London, United Kingdom, and the German Federal Ministry of Research of Education and Research (grant number BMBF 16KT0951) without any influence on study design, analysis, interpretation, or presentation.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top